RTC
AMGN icon

Riverview Trust Company’s Amgen AMGN Stock Holding History

Riverview Trust Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Sell
546
-26
-5% -$9.27K 0.24% 55
2025
Q4 		$187K Hold
572
– – 0.23% 61
2025
Q3 		$161K Hold
572
– – 0.2% 69
2025
Q2 		$160K Sell
572
-434
-43% -$123K 0.2% 68
2025
Q1 		$313K Hold
1,006
– – 0.31% 62
2024
Q4 		$262K Sell
1,006
-10
-1% -$2.97K 0.24% 74
2024
Q3 		$327K Buy
1,016
+10
+1% +$3.27K 0.29% 63
2024
Q2 		$314K Hold
1,006
– – 0.3% 61
2024
Q1 		$286K Buy
1,006
+100
+11% +$29.3K 0.22% 74
2023
Q4 		$261K Hold
906
– – 0.27% 85
2023
Q3 		$243K Buy
906
+381
+73% +$95.1K 0.22% 81
2023
Q2 		$117K Hold
525
– – 0.11% 126
2023
Q1 		$127K Hold
525
– – 0.12% 117
2022
Q4 		$138K Sell
525
-96
-15% -$25.7K 0.13% 115
2022
Q3 		$140K Buy
621
+96
+18% +$23.3K 0.14% 113
2022
Q2 		$128K Hold
525
– – 0.11% 130
2022
Q1 		$127K Buy
525
+419
+395% +$96.3K 0.09% 130
2021
Q4 		$24 Hold
106
– – 0.01% 197
2021
Q3 		$23K Hold
106
– – 0.02% 197
2021
Q2 		$26K Hold
106
– – 0.03% 191
2021
Q1 		$26K Hold
106
– – 0.03% 186
2020
Q4 		$24K Hold
106
– – 0.03% 190
2020
Q3 		$27K Hold
106
– – 0.03% 186
2020
Q2 		$25K Hold
106
– – 0.02% 194
2020
Q1 		$21K Sell
106
-1,288
-92% -$281K 0.02% 197
2019
Q4 		$336K Hold
1,394
– – 0.23% 78
2019
Q3 		$270K Hold
1,394
– – 0.19% 95
2019
Q2 		$257K Hold
1,394
– – 0.18% 94
2019
Q1 		$265K Buy
1,394
+26
+2% +$4.96K 0.2% 93
2018
Q4 		$266K Buy
+1,368
New +$267K 0.21% 82

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Riverview Trust Company's AMGN Position: Q1 2026 in Review

Riverview Trust Company reduced its Amgen (AMGN) stake by 4.5% in Q1 2026, selling an estimated $9.27K and leaving 546 shares worth $192K. The position accounts for 0.24% of the portfolio, ranked #55.

Riverview Trust Company first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $336K in Q4 2019. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Riverview Trust Company held 546 shares of Amgen worth $192K as of Q1 2026.
  • Riverview Trust Company sold 26 Amgen shares in Q1 2026, an estimated $9.27K.
  • Amgen made up 0.24% of Riverview Trust Company's portfolio in Q1 2026, its #55 holding.
  • Riverview Trust Company first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Riverview Trust Company's Amgen position peaked at $336K in Q4 2019.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Riverview Trust Company's 13F filing for Q1 2026, filed 1 May 2026.